Skip to main content
TipRanks
Go Ultimate75% OFF

Peter Langecker Insider Profile

4 Followers

Peter Langecker, CEO, Director at Oncotelic Therapeutics, holds 77.99K shares in Oncotelic Therapeutics (Ticker: OTLC), holds 800.00 shares in Durect (Ticker: DRRX), holds 0.00 shares in Bio Green Med Solution (Ticker: BGMS).

Peter Langecker's Trading History

OTLC
Oncotelic Therapeutics
Aug 09, 2013CEO, DirectorUninformative Buy―$1.01K
BGMS
Bio Green Med Solution
―Director―$0.00
DRRX
Durect
―――$1.53K

You May Also Like

Peter Langecker insider profile FAQ

What is the percentage of profitable transactions made by Peter Langecker?
The percentage of profitable transactions made by Peter Langecker is 0%.
What is the average return per transaction made by Peter Langecker?
The average return per transaction made by Peter Langecker is -4.10%.
What stocks does Peter Langecker hold?
Peter Langecker holds: OTLC, DRRX, BGMS stocks.
What was Peter Langecker's most profitable transaction?
Peter Langecker’s most profitable transaction was an Informative Buy of OTLC stock on July 1, 2013. The return on the trade was -2.20%.
What is Peter Langecker's role in Oncotelic Therapeutics?
Peter Langecker's role in Oncotelic Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.